期刊论文详细信息
Letter by Robinson Regarding Articles, Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One? and Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
Letter
DOI  :  10.1161/CIRCULATIONAHA.115.019345
来源: SCIE
【 授权许可】

Free   

  文献评价指标  
  下载次数:0次 浏览次数:0次